Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-08 Sale |
2021-03-09 7:26 pm |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
20,000 | $109.8 | $2,195,939 | 181,974 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-05 8:56 pm |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
35,550 | $105.04 | $3,734,075 | 118,295 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 8:28 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
60,000 | $137.48 | $8,249,038 | 681,213 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-02 9:50 pm |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
25,000 | $125.89 | $3,147,363 | 399,998 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-02 9:47 pm |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
30,000 | $126.73 | $3,801,918 | 581,796 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-08 9:08 pm |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
31,238 | $122.26 | $3,819,090 | 57,770 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 9:03 pm |
Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer |
10,300 | $120.43 | $1,240,406 | 339,921 (Direct) |
View |
| 2020-06-09 Sale |
2020-06-10 5:26 pm |
Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director |
9,500 | $65.81 | $625,194 | 1,841,681 (Indirect Direct) |
View |
| 2020-06-04 Sale |
2020-06-08 8:26 pm |
Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director |
55,500 | $64.16 | $3,560,648 | 1,851,181 (Indirect Direct) |
View |
| 2020-05-21 Purchase |
2020-05-26 5:57 pm |
Turning Point Therapeutics Inc. | TPTX | George Simeon Director |
83,333 | $60 | $4,999,980 | 2,253,660 (Indirect) |
View |
| 2020-05-21 Purchase |
2020-05-26 5:55 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
4,166 | $60 | $249,960 | 26,872 (Direct) |
View |
| 2020-05-21 Purchase |
2020-05-26 4:17 pm |
Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director |
83,333 | $60 | $4,999,980 | 2,253,660 (Indirect) |
View |
| 2020-05-19 Sale |
2020-05-21 7:05 pm |
Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director |
21,000 | $59.18 | $1,242,703 | 1,906,681 (Indirect Direct) |
View |
| 2020-05-08 Sale |
2020-05-12 8:09 pm |
Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director |
11,500 | $53.86 | $619,351 | 1,927,681 (Indirect Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 6:52 pm |
Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director |
55,500 | $53.27 | $2,956,634 | 1,939,181 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-08 Exercise |
2021-03-09 7:26 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
20,000 | $17 | 181,974 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-09 7:26 pm |
N/A 2029-04-14 |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
20,000 | $0 | 181,974 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 8:56 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
35,550 | $51.28 | 118,295 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 8:56 pm |
N/A 2030-03-01 |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
35,550 | $0 | 118,295 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 8:28 pm |
N/A 2028-06-05 |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
60,000 | $0 | 681,213 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 8:28 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
60,000 | $3.2 | 681,213 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 6:03 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer |
35,658 | $0 | 35,942 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 6:01 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
35,658 | $0 | 35,658 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:59 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
11,869 | $0 | 33,369 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:58 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
25,392 | $0 | 28,096 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:55 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
21,148 | $0 | 21,148 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:53 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
8,158 | $0 | 9,166 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:52 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
124,392 | $0 | 151,970 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-02 9:50 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
25,000 | $17 | 399,998 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-02 9:50 pm |
N/A 2029-04-14 |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
25,000 | $0 | 399,998 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-02 9:47 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
30,000 | $54.03 | 581,796 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-02 9:47 pm |
N/A 2029-08-25 |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
30,000 | $0 | 581,796 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-08 9:08 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
11,905 | $2.19 | 57,770 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-08 9:08 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
4,545 | $5.12 | 57,770 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-08 9:08 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
10,689 | $7.43 | 57,770 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-08 9:08 pm |
N/A 2027-08-08 |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
28,438 | $0 | 57,770 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-08 9:08 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
1,299 | $3.2 | 57,770 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-05 9:03 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer |
10,000 | $54.73 | 339,921 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-05 9:03 pm |
N/A 2029-12-01 |
Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer |
10,000 | $0 | 339,921 (Direct) |
View |
| 2020-07-13 Option Award |
2020-07-14 5:40 pm |
N/A 2030-07-12 |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
149,000 | $0 | 149,000 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 7:09 pm |
N/A 2030-06-14 |
Turning Point Therapeutics Inc. | TPTX | Gujrathi Sheila Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 7:06 pm |
N/A 2030-06-14 |
Turning Point Therapeutics Inc. | TPTX | Machado Patrick Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 7:02 pm |
N/A 2030-06-14 |
Turning Point Therapeutics Inc. | TPTX | Chacko Jacob Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 6:58 pm |
N/A 2030-06-14 |
Turning Point Therapeutics Inc. | TPTX | George Simeon Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 6:54 pm |
N/A 2030-06-14 |
Turning Point Therapeutics Inc. | TPTX | GORDON CARL L Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 6:51 pm |
N/A 2030-01-21 |
Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director |
23,400 | $0 | 23,400 (Direct) |
View |
| 2019-08-27 Gift |
2020-06-17 6:47 pm |
N/A 2029-07-23 |
Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director |
60,000 | $0 | 38,500 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 6:47 pm |
N/A 2030-06-14 |
Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director |
8,500 | $0 | 38,500 (Direct) |
View |